Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX | Publicación